Increased vasopressin and adrenocorticotropin responses to stress in the midluteal phase of the menstrual cycle

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 6, 2001, Pages 2525-2530

  Altemus, Margaret ^a   Roca, Catherine ^a,b   Galliven, Elise ^c   Romanos, Catherine ^a,b   Deuster, Patricia ^c  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; ESTROGEN; GLUCOSE; PROGESTERONE; VASOPRESSIN;

ADULT; ARTICLE; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; FEMALE; FOLLICULAR PHASE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LUTEAL PHASE; MENSTRUAL CYCLE; OXYGEN CONSUMPTION; PRIORITY JOURNAL; STRESS; TREADMILL EXERCISE; VASOPRESSIN BLOOD LEVEL;

EID: 0034974835     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.86.6.7596     Document Type: Article

References (66)

1. Induction of corticotropin-releasing hormone gene expression by glucocorticoids: Implication for understanding the states of fear and anxiety and allostatic load
2. Physiological functions of glucocorticoids in stress and their relations to pharmacological actions
3. Glucocorticoid suppression of the sympathetic nervous system and adrenal medulla
4. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis
5. Antidepressants regulate glucocorticoid receptor messenger RNA concentrations in primary neuronal cultures
6. Effects of chronic imipramine treatment on glucocorticoid receptor immunoreactivity in various regions of the rat brain: Evidence for selective increases of glucocorticoid receptor immunoreactivity in the locus coeruleus and in 5-hydroxytryptamine nerve cell groups of the rostral ventromedial medulla
7. Reduced sensitivity to glucocorticoid feedback and reduced glucocorticoid receptor mRNA expression in the luteal phase of the menstrual cycle
8. Acute hypothalamic-pituitary-adrenal responses to the stress of treadmill exercise
9. Hormonal and metabolic responses of untrained, moderately trained, and highly trained men to three exercise intensities
10. Prospective assessment of menstrually related mood disorders
11. Suppression of hypothalamic-pituitary adrenal axis responses to stress in lactating women
12. Abnormalities in the regulation of vasopressin and corticotropin releasing factor secretion in obsessive-compulsive disorder
13. CSF oxytocin in anorexia nervosa and bulimia nervosa: Clinical and pathophysiologic considerations
14. Menstrual cycle status and adrenocortical reactivity to psychological stress
15. Impact of gender, menstrual cycle phase, and oral contraceptives on the activity of the hypothalamic-pituitary-adrenal axis
16. Menstrual cycle phase dissociation of blood glucose homeostasis during exercise
17. Cortisol levels during prolonged exercise: The influence of menstrual phase and menstrual status
18. Effects of menstrual cycle on metabolic responses to exercise
19. Adrenal activation and prolactin response to exercise in eumenorrheic and amenorrheic runners
20. Hormonal and metabolic responses to exercise across time of day and menstrual cycle phase
21. Stress and the menstrual cycle: Short- and long-term response to a five-day endotoxin challenge during the luteal phase in the rhesus monkey
22. Psychoneuroendocrine stress responses and mood as related to the menstrual cycle
23. Cortisol and growth hormone responses to psychological stress during the menstrual cycle
24. Cortisol, 17α-OH-progesterone, and androgen response to a standardized ACTH-stimulation in different stages of the normal menstrual cycle
25. The menstrual cycle and exercise performance, muscle glycogen, and substrate responses
26. Menstrual cyclicity has a profound effect on glucose homeostasis
27. Changes in oral glucose tolerance during the menstruation cycle
28. Responses to laboratory psychosocial stress in postpartum women
29. Psychological stress of exposure to uncontrollable noise increases plasma oxytocin in high emotionality women
30. Exploring the biological basis of attachment: Relationships among oxytocin, prolactin and interpersonal traits in healthy women
31. Breast stimulation in cycling women, pregnant women and a woman with induced lactation: Pattern of release of oxytocin, prolactin and luteinizing hormone
32. Oxytocin as part of stress responses
33. Inhibitory effect of exogenous oxytocin on ACTH and cortisol secretion during labour
34. Oxytocin reduces metyrapone-induced ACTH secretion in human subjects
35. Sex differences in response to exogenous corticosterone
36. Vasopressinergic control of pituitary adrenocorticotropin secretion comes of age
37. Vasopressin stimulates cortisol secretion from human adrenocortical tissue through activation of V1 receptors
38. Plasma and urinary catecholamines during the human ovulatory cycle
39. Dysregulation of cardiovascular and neuroendocrine responses to stress in premenstrual dysphoric disorder
40. Blunting of neuroendocrine responses to infusion of 1-tryptophan in women with perimenstrual mood change
41. Effect of menstrual cycle phase on neuroendocrine and behavioral responses to the serotonin agonist m-chlorophenylpeperazine in women with premenstrual syndrome and controls
42. d-Fenfuramine/prolactin response throughout the menstrual cycle: Evidence for an oestrogen-induced alteration
43. Chronic estrogen-induced alterations in adrenocorticotropin and corticosterone secretion, and glucocorticoid receptor-mediated functions in female rats
44. Variations in the hypothalamic-pituitary-adrenal response to stress during the estrous cycle in the rat
45. Estradiol abolishes autologous down regulation of glucocorticoid receptors in brain
46. Hormonal regulation of type II glucocorticoid receptor messenger ribonucleic acid in rat brain
47. Estrogen-induced alterations in the regulation of mineralocorticoid and glucocorticoid receptor messenger RNA expression in the female rat anterior pituitary gland and brain
48. Androgen regulation of adrenocorticotropin and corticosterone secretion in the male rat following novelty and foot shock stressors
49. A 5-day estradiol therapy, in amounts reproducing concentrations of the early-mid follicular phase, prevents the activation of the hypothalamo-pituitary-adrenal axis by interleukin-1α in the ovariectomized rhesus monkey
50. Stimulatory effects of interleukin-induced activation of the hypothalamo-pituitary-adrenal axis on gonadotropin secretion in ovariectomized monkeys replaced with estradiol
51. Short-term estradiol treatment enhances pituitary-adrenal axis and sympathetic responses to psychosocial stress in healthy young men
52. Behavioral stress responses in premenopausal and postmenopausal women and the effects of estrogen
53. Estrogen supplementation attenuates glucocorticoid and catecholamine responses to mental stress in perimenopausal women
54. Postmenopausal hormone replacement: Effects on autonomic, neuroendocrine, and immune reactivity to brief psychological stressors
55. Progesterone enhances glucocorticoid dissociation from the AT-20 cell glucocorticoid receptor
56. Demonstration of an antiglucocorticoid action of progesterone on the corticosterone inhibition of β-endorphin release by rat anterior pituitary in primary culture
57. Estrogen-induced decrease of glucocorticoid receptor messenger ribonucleic acid concentration in rat anterior pituitary gland
58. Implications of estrogen-dependent brain organization for gender difference in hypothalamic-pituitary-adrenal regulation
59. The influence of ovarian steroids on hypothalamic-pituitary-adrenal regulation in the female rat
60. Gonadal steroid modulation of oxytocin and vasopressin gene expression in the hypothalamus of the osmotically stimulated rat
61. The epidemiology and social impact of premenstrual symptoms
62. Premenstrual complaints. I. Prevalence of premenstrual symptoms in a Swedish urban population
63. Late luteal phase dysphoric disorder in young women
64. The epidemiology of premenstrual symptoms in a population based sample of 2650 urban women: Attributable risk and risk factors
65. Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress